sharecast

{{ storiesRelated.title }}

AstraZeneca (AZN)

8,292.00p

15:45 26/07/21

  • -2.22% -188.00p
  • Today's Low & High
  • 8,257.00 / 8,493.00
  • Open / Previous Close
  • 8,489.00 / 8,292.00
  • 52-week range
  • -4.16% -360.00p
  • Volume
  • 1,687,632
  • Market Cap(billion)
  • £128.45b

8,276.00p REAL TIME BATS

  • 16:30 26/07/21
  • -2.51%
  • -213.00p

KEY FINANCIALS

  Latest Forecast
Div Yield 2.4% 2.4%
Div Cover 0.9 1.9
Op Mrgn 19.4% 26.9%
ROCE 76.3%  
  Latest Forecast
P/E 47.0 22.7
PEG 0.3 0.2
Price / Revenue 6.7 5.6
Price / Book value 11.4  
  Latest Forecast
Revenue 9.2% -1.8%
PBT 153.0% n/a
EPS 136.9% -2.3%
DPS 0.0% -10.8%

KEY FUNDAMENTALS

Year Ending Revenue
($m)		 Pre-tax
($m)		 EPS P/E PEG EPS Growth Div Yield
2016-12-31 23,002.00 3,552.00 $4.31 12.7 10.8 1% $2.80 5.1%
2017-12-31 22,465.00 2,227.00 $4.28 16.2 -23.2 -1% $2.80 4.0%
2018-12-31 22,090.00 1,993.00 $1.70 44.0 -0.7 -60% $2.80 3.7%
2019-12-31 24,384.00 1,548.00 $1.03 97.9 -2.5 -39% $2.80 2.8%
2020-12-31 26,617.00 3,916.00 $2.44 41.0 0.3 137% $2.80 2.8%

Latest Webfg News
AstraZeneca's 'Ultomiris' gets EU approval for use in children Sharecast News 26 Jul
Jefferies believes Delta may be less lethal than other variants Sharecast News 20 Jul
AstraZeneca lung cancer drug approved in China Sharecast News 19 Jul

Regulatory News

Ultomiris recommended in EU for children with PNH 26-Jul-21 07:00
Directorate Change 22-Jul-21 07:00
Director/PDMR Shareholding 21-Jul-21 15:56
Total Voting Rights 21-Jul-21 15:45
Acquisition of Alexion completed 21-Jul-21 13:45